Norwegian health authorities say there is no evidence of a link between the vaccination campaign and the deaths of elderly people who have been vaccinated. In Scandinavia, a total of 13 deaths were recorded among elderly people who had received the first dose since the vaccination campaign began at the end of December. The report also recommends vaccinating the elderly or the most vulnerable, but not the young. The Norwegian health authority NPHA said that of the 13 cases investigated so far, all were from people who were very old, frail or seriously ill.
The most important thing is to remember that in Norway, 45 people die every day in medical facilities. There is no analysis of the cause of death, “said Dr. Jorgen Eriksen, head of the public health agency NPHA.
It is not impossible that there are vaccines that are so dangerous that it is worth vaccinating against them, although their condition may worsen, while normal secondary vaccinations are not effective, “Stoltenberg said Monday. There is no evidence that the vaccine is linked to excessive mortality, but Norway should not repeat the practice of distributing vaccines to very sensitive or dying people, as has already been the case in other countries.
Several countries have reported deaths after vaccination, and health officials believe a link can be established between the vaccine. The Norwegian Medicines Agency has expressed concerns in the past, claiming that the use of high doses of vaccine in very sensitive patients may have contributed to fatal outcomes for some of them, according to the Norwegian Medical Association.
Pfizer BioNTech told AFP news agency on Monday that it was working with the Norwegian drug agency to gather relevant information. The Norwegian vaccination campaign, which began with elderly people in medical facilities, was recalled by Pfizer’s Bio NTech. Most were very old or sick, some were terminally ill and some were vaccinated, “Pfizer said. In total, more than 48,000 people have been vaccinated in Norway, according to the National Health and Medical Research Council (NHMRC).